Content area

|
|

Når lægemidler udløser lupus i huden

Forfatter(e)
Kathrine Balslev Skovmøller1 & Anette Bygum2

1) Sundhedsvidenskabeligt Fakultet, Syddansk Universitet

2) Hudafdeling I og Allergicentret, Odense Universitetshospital

Ugeskr Læger 2018;180:V04180277

Reference: 
Ugeskr Læger 2018;180:V04180277
Blad nummer: 

Kathrine Balslev Skovmøller & Anette Bygum:

When drugs induce cutaneous lupus erythematosus

Ugeskr Læger 2018;180:V04180277

Drug-induced subacute cutaneous lupus erythematosus (DI-SCLE) is defined as an adverse reaction to continuous use of a culprit drug. The reaction resolves upon drug withdrawal. More than 50 drugs have been linked to DI-SCLE, and it is estimated, that around 20% of the SCLE cases are drug-induced. There are no diagnostic criteria, yet detection of anti-Ro/SSA antibodies combined with erosive/bullous or erythema multiforme/toxic epidermal necrolysis-like lesions, and widespread skin rash seem to be indicative of DI-SCLE. The most common drugs involved are proton pump inhibitors, terbinafine, thiazides and chemotherapeutics.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Hans Erik Brygger | 24/06
3 kommentarer
af Jennifer Vikre-Jørgensen | 22/06
2 kommentarer
af Susanne L. M. Bülow | 19/06
2 kommentarer
af Niels Ejnar Bie | 18/06
2 kommentarer
af Hanne Hermann | 17/06
1 Kommentar
af Julius Vindbjerg Nissen | 17/06
1 Kommentar
af Peter Tagmose Thomsen | 15/06
1 Kommentar